InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Hassan Fred, Director. Officer active across 2 companies, notably BridgeBio Pharma, Inc.. In total, 4 filings have been published. Total volume traded: €483k. The latest transaction was disclosed on 22 February 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
16,212 shares
Common Stock
SEC:0000950103-22-005404:0·
€49,95627,832 shares@ €1.79490.0032% mcap100.0% of flow
Common Stock
SEC:0000950103-22-003221:0·
€241,62219,300 shares@ €12.51930.0016% mcap50.0% of flow
Common Stock
SEC:0000899243-22-000176:0·
Ideal exit: 25 Sept 2022 (T+270)
€241,62219,300 shares@ €12.51930.0016% mcap100.0% of flow
Common Stock
SEC:0000899243-22-000176·
Ideal exit: 25 Sept 2022 (T+270)
4 of 4 declarations
About Hassan Fred
Fred Hassan serves as a Board Member at BridgeBio Pharma, Inc. and Precigen, Inc. In this role, he participates in the governance of these companies and strategic decision-making. Fred Hassan brings expertise in biopharmaceuticals and management, contributing to the direction of BridgeBio and Precigen in the healthcare sector. His commitment to best governance practices is essential for the success of these companies.
